Location History:
- Oslo, NO (2014 - 2015)
- Drøbak, NO (2022)
Company Filing History:
Years Active: 2014-2022
Title: Innovations of Geir Åge Løset: A Pioneer in Phage Technology
Introduction
Geir Åge Løset is an accomplished inventor based in Oslo, Norway, known for his significant contributions to biotechnology, particularly in the field of phage technology. With a portfolio of three patents, Løset's work has paved the way for innovative solutions in protein display systems and secretory pathways.
Latest Patents
Løset's latest inventions showcase his expertise and creativity. One of his prominent patents is the "Vector Construct," which presents a vector that includes a sequence encoding a signal peptide to direct proteins into the Tat secretory pathway. It also features a sequence that encodes a fluorophore fused with a sequence for the pVIII phage coat protein. His invention further encompasses nucleic acid molecules and phage particles that express a fluorophore-pVIII fusion protein on their surface. The methods for producing these fluorescent phage particles enhance the utility of phage display in various applications.
Another noteworthy patent is focused on "Signal Sequence-independent pIX Phage Display." This invention introduces a novel scaffold for displaying peptides on filamentous phages, utilizing innovative fusion proteins derived primarily from pIX. It involves the creation of libraries of filamentous phages from these fusion proteins, contributing to advancements in phage display systems that include a phagemid and a helper phage. A significant aspect of this invention is the provision of a kit that comprises this advanced phage display system.
Career Highlights
Working at Nextera AS, Geir Åge Løset has excelled in his research and development efforts, leading to groundbreaking patents that address modern challenges in biotechnology. His focus on enhancing phage display systems illustrates his commitment to pushing the boundaries of scientific innovation.
Collaborations
Løset collaborates with talented peers such as Terje Frigstad and Sebastian Berge-Seidl, contributing collectively to the advancement of their field. These collaborations have undoubtedly enriched the development of their innovative technologies and fostered a culture of creativity and excellence within their organization.
Conclusion
Geir Åge Løset's contributions to the realm of biotechnology through his inventive patents lay a strong foundation for future advancements. His commitment to innovation and collaboration continues to inspire the scientific community and shapes the future of phage technology.